Abstracts tagged "Classification criteria and polymyalgia rhuematica"

Abstract Number: 2769 • 2014 ACR/ARHP Annual Meeting
Validation of New 2012 EULAR/ACR Classification Criteria for Polymyalgia Rheumatica: Comparison with the Previous Criteria in a Prospective Multi-Center Study
Gulsen Ozen¹, Seda Bas², Ali Ugur Unal², Gezmis Kimyon³, Ahmet Mesut Onat⁴, Meryem Can⁵, Alperen Mengi⁵, Ali Sahin⁶, Sema Yilmaz⁷, Havva Keskin⁸, Sadiye Murat⁸, Ayse Balkarli⁹, Veli Cobankara⁹, Omer Nuri Pamuk¹⁰, Yonca Cagatay¹¹, Neslihan Yilmaz¹¹, Ilker Yagci¹², Pamir Atagunduz², Sibel Z. Aydin¹³, Nevsun Inanc² and Haner Direskeneli², ¹Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, ²Department of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, ³Department of Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁴Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁵Department of Rheumatology, Fatih Sultan Mehmet Education and Research Hospital, Istanbul, Turkey, ⁶Department of Rheumatology, Cumhuriyet University Faculty of Medicine, Sivas, Turkey, ⁷Department of Rheumatology, Selcuk University School of Medicine, Konya, Turkey, ⁸Department of Physical Medicine and Rehabilitation, Goztepe Medeniyet University Faculty of Medicine, Istanbul, Turkey, ⁹Department of Rheumatology, Pamukkale University School of Medicine, Denizli, Turkey, ¹⁰Department of Rheumatology, Trakya University School of Medicine, Edirne, Turkey, ¹¹Department of Rheumatology, Bilim University Faculty of Medicine, Istanbul, Turkey, ¹²Department of Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey, ¹³Department of Rheumatology, Koc University Faculty of Medicine, Istanbul, Turkey
Background/Purpose: To evaluate the diagnostic and discriminative ability of the new 2012 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) polymyalgia rheumatica (PMR) classification…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].